COVID ‐19: immunopathology, pathophysiological mechanisms, and treatment options
COVID-19: иммунопатология, патофизиологические механизмы и варианты лечения
2021-02-16
SCID: 54.1/d7m4ptq2
Discuss with AI
COVID-19 immunopathologyCOVID-19 vaccinesSARS-CoV-2 infectionacute respiratory distress syndromemulti-organ failure
Figures from the paper
Abstract (AI)
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally despite the worldwide implementation of preventive measures to combat the disease. Although most COVID-19 cases are characterised by a mild, self-limiting disease course, a considerable subset of patients develop a more severe condition, varying from pneumonia and acute respiratory distress syndrome (ARDS) to multi-organ failure (MOF). Progression of COVID-19 is thought to occur as a result of a complex interplay between multiple pathophysiological mechanisms, all of which may orchestrate SARS-CoV-2 infection and contribute to organ-specific tissue damage. In this respect, dissecting currently available knowledge of COVID-19 immunopathogenesis is crucially important, not only to improve our understanding of its pathophysiology but also to fuel the rationale of both novel and repurposed treatment modalities. Various immune-mediated pathways during SARS-CoV-2 infection are relevant in this context, which relate to innate immunity, adaptive immunity, and autoimmunity. Pathological findings in tissue specimens of patients with COVID-19 provide valuable information with regard to our understanding of pathophysiology as well as the development of evidence-based treatment regimens. This review provides an updated overview of the main pathological changes observed in COVID-19 within the most commonly affected organ systems, with special emphasis on immunopathology. Current management strategies for COVID-19 include supportive care and the use of repurposed or symptomatic drugs, such as dexamethasone, remdesivir, and anticoagulants. Ultimately, prevention is key to combat COVID-19, and this requires appropriate measures to attenuate its spread and, above all, the development and implementation of effective vaccines. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
Key Findings
1
COVID-19 severity ranges from mild, self-limiting illness to pneumonia, acute respiratory distress syndrome, and multi-organ failure.
2
Current management combines supportive care with repurposed or symptomatic therapies, including dexamethasone, remdesivir, and anticoagulants.
3
Disease progression reflects interactions among innate immunity, adaptive immunity, autoimmunity, and other pathophysiological mechanisms that drive organ-specific tissue damage.
4
Effective prevention depends primarily on measures that reduce transmission and the development and implementation of effective vaccines.
5
Pathological examination of patient tissues provides insights into COVID-19 pathophysiology and supports development of evidence-based treatment strategies.
Research Object
COVID-19 (SARS-CoV-2 infection)
Research Subject
Immunopathology, pathophysiological mechanisms, organ-specific tissue damage, and treatment options
Publication Details
Publication Date
2021-02-16
Journal
Publisher
ISSN
Cited by
156
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai13
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China2020
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-192020
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis2004
A first case of meningitis/encephalitis associated with SARS-Coronavirus-22020
Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China2020
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction2020
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings2020
Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)2020
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study2020
Two distinct immunopathological profiles in autopsy lungs of COVID-192020
Neuropathologic features of four autopsied COVID‐19 patients2020
Histopathological observations in COVID-19: a systematic review2020
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside2020